This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Nov 17;358(6365):865-866.

doi: 10.1126/science.aaq0215.

Advancing dengue vaccine development

Mark B Feinberg¹, Rafi Ahmed²

Affiliations

Affiliations

¹ International AIDS Vaccine Initiative, New York, NY, USA. mfeinberg@iavi.org.
² Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.

PMID: 29146795
DOI: 10.1126/science.aaq0215

Comment

Advancing dengue vaccine development

Mark B Feinberg et al. Science. 2017.

. 2017 Nov 17;358(6365):865-866.

doi: 10.1126/science.aaq0215.

Authors

Mark B Feinberg¹, Rafi Ahmed²

Affiliations

¹ International AIDS Vaccine Initiative, New York, NY, USA. mfeinberg@iavi.org.
² Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.

PMID: 29146795
DOI: 10.1126/science.aaq0215

No abstract available

PubMed Disclaimer

Comment on

Antibody-dependent enhancement of severe dengue disease in humans.
Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. Katzelnick LC, et al. Science. 2017 Nov 17;358(6365):929-932. doi: 10.1126/science.aan6836. Epub 2017 Nov 2. Science. 2017. PMID: 29097492 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

U19 AI057266/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information